NIH #1R41AI149954-01
An adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment
- Amount
- $224K
- Period
- 2020-02-10 → 2022-04-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at POP BIOTECHNOLOGIES, INC
Genomics and Phylogenetic Studies · Molecular Biology
1 total · 0 active
NIH #1R41AI149954-01
Awarded at POP BIOTECHNOLOGIES, INC
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Genome assortment, not serogroup, defines Vibrio cholerae pandemic strains
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) · 2024-02-05